Your browser doesn't support javascript.
loading
Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival.
Sammer, Matthias; Girst, Stefanie; Dollinger, Günther.
Affiliation
  • Sammer M; Institut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, 85579, Neubiberg, Germany. matthias.sammer@unibw.de.
  • Girst S; Institut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, 85579, Neubiberg, Germany.
  • Dollinger G; Institut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, 85579, Neubiberg, Germany.
Sci Rep ; 11(1): 3533, 2021 02 11.
Article in En | MEDLINE | ID: mdl-33574390
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Proton Therapy / Radiation Dose Hypofractionation / Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Dosage / Proton Therapy / Radiation Dose Hypofractionation / Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Country of publication: